FDA Warning Letters - October 2007
This article was originally published in The Silver Sheet
Executive Summary
WARNING LETTERS: Medtronic cited for premarket violations in relation to its Satellite spinal system; Boston Scientific Cardiovascular allegedly violates IDE clinical trials regulation